ARV-806

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationNCT07023731ARVNPhase 1, Phase 2Completed2026-10-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.